Article Text

Download PDFPDF
Lung alert
Treatment with β-blockers may reduce exacerbations and mortality in patients with COPD
  1. L Castle
  1. Correspondence to L Castle, Specialist Registrar, Department of Respiratory Medicine, Churchill Hospital, Oxford OX3 7LJ, UK; liannecastle{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Cardiovascular disease is a significant burden in patients with chronic obstructive pulmonary disease (COPD). Shortness of breath and fatigue may be misinterpreted as symptoms of COPD, leaving cardiovascular disease unrecognised. Beta-blockers improve survival in ischaemic heart disease and heart failure. Many physicians avoid prescribing β-blockers in COPD because of concerns regarding bronchoconstriction and …

View Full Text